Currently, there are 1.26B common shares owned by the public and among those 1.26B shares have been available to trade.
The company’s stock has a 5-day price change of 20.78% and 20.82% over the past three months. CVS shares are trading 46.07% year to date (YTD), with the 12-month market performance down to -14.19% lower. It has a 12-month low price of $43.56 and touched a high of $80.75 over the same period. CVS has an average intraday trading volume of 13.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 14.56%, 25.95%, and 15.13% respectively.
Institutional ownership of CVS Health Corp (NYSE: CVS) shares accounts for 84.21% of the company’s 1.26B shares outstanding.
It has a market capitalization of $82.67B and a beta (3y monthly) value of 0.56. The stock’s trailing 12-month PE ratio is 17.93, while the earnings-per-share (ttm) stands at $3.66. The company has a PEG of 1.30 and a Quick Ratio of 0.60 with the debt-to-equity ratio at 1.10. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.25% over the week and 3.04% over the month.
Earnings per share for the fiscal year are expected to increase by 8.68%, and 16.99% over the next financial year. EPS should grow at an annualized rate of 13.79% over the next five years, compared to -6.37% over the past 5-year period.
Looking at the support for the CVS, a number of firms have released research notes about the stock. Leerink Partners stated their Outperform rating for the stock in a research note on February 13, 2025, with the firm’s price target at $55-$75. Edward Jones was of a view on January 30, 2025 that the stock is Buy, while Deutsche Bank gave the stock Buy rating on December 03, 2024, issuing a price target of $66. Wells Fargo on their part issued Overweight rating on November 18, 2024.
